| 000 | 01921 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515140422.0 | ||
| 264 | 0 | _c20081126 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a1538-7445 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-08-1296 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVogler, Meike | |
| 245 | 0 | 0 |
_aTargeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. _h[electronic resource] |
| 260 |
_bCancer research _cOct 2008 |
||
| 300 |
_a7956-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, bcl-2 _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xadministration & dosage |
| 650 | 0 | 4 |
_aTNF-Related Apoptosis-Inducing Ligand _xadministration & dosage |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aX-Linked Inhibitor of Apoptosis Protein _xantagonists & inhibitors |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aWalczak, Henning | |
| 700 | 1 | _aStadel, Dominic | |
| 700 | 1 | _aHaas, Tobias L | |
| 700 | 1 | _aGenze, Felicitas | |
| 700 | 1 | _aJovanovic, Marjana | |
| 700 | 1 | _aGschwend, Jürgen E | |
| 700 | 1 | _aSimmet, Thomas | |
| 700 | 1 | _aDebatin, Klaus-Michael | |
| 700 | 1 | _aFulda, Simone | |
| 773 | 0 |
_tCancer research _gvol. 68 _gno. 19 _gp. 7956-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-08-1296 _zAvailable from publisher's website |
| 999 |
_c18295865 _d18295865 |
||